Seeking Alpha

Avanir Pharmaceuticals (AVNR) falls off 6.4% after an SEC filing tips off insider selling....

Avanir Pharmaceuticals (AVNR) falls off 6.4% after an SEC filing tips off insider selling. Shares are now threatening their 52-week low.
Comments (1)
  • capappman
    , contributor
    Comments (24) | Send Message
     
    The fundamentals are still strong for AVNR, and IMO the heavy contingent of shorts will ultimately get caught with their pants down on this one.
    22 Nov 2011, 10:59 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs